Navigation Links
Max Neeman International ISO 27001:2005 Certified for Information Security Management Systems
Date:1/5/2011

RESEARCH TRIANGLE PARK, N.C., Jan. 5, 2011 /PRNewswire/ -- Max Neeman announces the grant of ISO 27001:2005 certificate; one of only a few Indian CROs to be certified for Information Security.  

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

This updated certification of the world renowned British Standard for Information Security Management Systems (BS 7799-2:2002) is the standard outlining requirements for an Information Security Management System (ISMS). An ISMS helps in designing; implementing and maintaining a set of processes and systems to manage the risk posed to the information assets of an organization. Thus, helps in achieving the standards of – confidentiality, integrity and availability necessary for information security.

India is the hub of outsourced clinical research and this growth can be impeded by the threat posed to the security of the data generated in the trials. Sponsor companies have been seen to be apprehensive about information security.  

Max Neeman is involved in the development of various novel research molecules and handles crucial information related to the development of these molecules. ISO 27001 certification assures that the systems, processes and controls are rigorous to protect the integrity and confidentiality of information.  The certification helps Max Neeman in assuring the clients on integrity and confidentiality of the data generated in clinical research.  

The ISO 27001:2005 certification Max Neeman has achieved, assures that systems, processes and controls are stringent and sound enough to protect the integrity and confidentiality of information. Max Neeman is in par with all the other global Contract Research Organizations and in meeting global standards.

About Max Neeman International

Max Neeman International is a leading India-based CRO. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in over 31 cities with 6 regional offices.  Contact Donald Swankie, Vice President of Business Development via email to donald.swankie@neeman-medical.com or call +1.919.424.3345.  For more information please visit www.neeman-medical.com.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
2. Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
3. Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
4. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
5. Max Neeman International Expands Specialized Surgical Team for Clinical Trials
6. Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells
7. Dongsheng Pharmaceutical International Co. Granted Exclusive Sales Rights for Thymosin Alpha 1 Injection
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference
9. PAREXEL International to Present at J.P. Morgan Healthcare Conference
10. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
11. SRI International Completes Integration of Sarnoff Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):